Predictive Value of Circulating Tumor Cells and Circulating Free DNA in NSCLC Patients Treated with Nivolumab

被引：0
|
作者：
Rossi, G. [1 ]
Tagliamento, M. [1 ]
Alama, A. [1 ]
Coco, S. [1 ]
Genova, C. [1 ]
Rijavec, E. [1 ]
Barletta, G. [1 ]
Biello, F. [1 ]
Vanni, I. [1 ]
Boccardo, S. [1 ]
Dal Bello, M. G. [1 ]
Alessandra, R. [2 ]
Fontana, V. [2 ]
Grossi, F. [1 ]
机构：
[1] Osped Policlin San Martino, Lung Canc Unit, Genoa, Italy
[2] Osped Policlin San Martino, Clin Epidemiol Unit, Genoa, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
circulating free DNA; Circulating tumor cells; Immunotherapy;
D O I：
10.1016/j.jtho.2018.08.1226
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.04-02
引用
收藏
页码：S730 / S731
页数：2
相关论文
共 50 条
  • [31] Predictive and prognostic value of circulating tumor DNA (ctDNA) compared to circulating tumor cells (CTC) in a prospective cohort of metastatic breast cancer patients: The UCBG COMET trial
    Pierga, Jean-Yves
    Silveira, Amanda
    Girard, Elodie
    Lorgis, Veronique
    Tanguy, Marie-Laure
    Albaud, Benoit
    Tredan, Olivier
    Dubot, Coraline
    Hego, Caroline
    Jacot, William
    Goncalves, Anthony
    Debled, Marc
    Levy, Christelle
    Ferrero, Jean-Marc
    Jouannaud, Christelle
    Mouret-Reynier, Marie-Ange
    Dalenc, Florence
    Baulande, Sylvain
    Lemonnier, Jerome
    Berger, Frederique
    Bidard, Francois-Clement
    Proudhon, Charlotte
    CANCER RESEARCH, 2020, 80 (16)
  • [32] A prospective evaluation of cell free DNA (cfDNA) genotyping and circulating tumor cells (CTC) in EGFR mutant NSCLC patients (pts) treated with erlotinib.
    Yanagita, Masahiko
    Paweletz, Cloud
    O'Connell, Allison
    Jackman, David Michael
    Kuang, Yanan
    Oxnard, Geoffrey R.
    Janne, Pasi A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] Circulating Tumor Cells and Circulating Tumor DNA in Colorectal Cancer
    Suhaimi, Nur-Afidah Mohamed
    Tan, Min-Han
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2016, 1 (02): : 181 - 194
  • [34] Circulating tumor cells and circulating tumor DNA in colon cancer
    Fedyanin, Mikhail
    Polyanskaya, Elizaveta
    Tjulandin, Sergei
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2016, 9 (02) : 88 - 92
  • [35] Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma
    Bidard, Francois-Clement
    Madic, Jordan
    Mariani, Pascale
    Piperno-Neumann, Sophie
    Rampanou, Aurore
    Servois, Vincent
    Cassoux, Nathalie
    Desjardins, Laurence
    Milder, Maud
    Vaucher, Isabelle
    Pierga, Jean-Yves
    Lebofsky, Ronald
    Stern, Marc-Henri
    Lantz, Olivier
    INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (05) : 1207 - 1213
  • [36] Predictive value of circulating tumor cells in patients with metastatic breast cancer treated with chemotherapy or hormonotherapy:: preliminary results.
    Minchella, I
    Sandri, M. T.
    Medici, M.
    Zorzino, L.
    Botteri, E.
    Adamoli, L.
    Franceschelli, L.
    Magni, E.
    Verri, E.
    Cossu Rocca, M.
    Colleoni, M.
    Goldhirsch, A.
    Nole, F.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S137 - S137
  • [37] A Pilot Study to Assess Circulating Tumor Cells, Circulating Tumor Cell DNA and Cell Free DNA in Patients with Small Cell Lung Cancer
    Aggarwal, Charu
    Badola, Sunita
    Shin, Hyunjin
    Bedford, Lisa
    Collins, Sabrina
    Derk, Blair
    Fostel, Jen
    Ecsedy, Jeffrey
    Evans, Tracey
    Bauml, Joshua
    Cohen, Roger
    Vachani, Anil
    Langer, Corey
    Niu, Huifeng
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1527 - S1527
  • [38] Quantification of circulating free and circulating tumor DNA in pretreated EGFR mutant NSCLC to inform patient outcomes.
    Pender, Alexandra
    Hughesman, Curtis
    Law, Elaine
    Kristanti, Amadea
    McNeil, Kelly
    Tucker, Tracy
    Bosdet, Ian
    Young, Sean
    Laskin, Janessa J.
    Karsan, Aly
    Yip, Stephen
    Ho, Cheryl
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [39] Integration of tissue and circulating parameters identifies a favorable immune profile in NSCLC patients treated with nivolumab
    Mazzaschi, G.
    Facchinetti, F.
    Madeddu, D.
    Buti, S.
    Gelsomino, F.
    Ardizzoni, A.
    Aversa, F.
    Missale, G.
    Quaini, F.
    Tiseo, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S1 - S1
  • [40] Circulating immune-profile as predictor of outcome in advanced NSCLC patients treated with nivolumab.
    Tiseo, Marcello
    Veneziani, Michele
    Gelsomino, Francesco
    Buti, Sebastiano
    Facchinetti, Francesco
    Squadrilli, Anna
    Bordi, Paola
    Bersanelli, Melissa
    Cosenza, Agnese
    Ferri, Leonarda
    Rapacchi, Elena
    Mazzaschi, Giulia
    Leonardi, Francesco
    Quaini, Federico
    Ardizzoni, Andrea
    Missale, Gabriele
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345